Moolec Science SA balance sheet
At the end of fiscal 2025, Moolec Science SA had total assets of $205m, total liabilities of $288m and shareholders' equity of −$66.0m. It held $767,919 in cash against $1.3m of debt: net debt of $580,254.
Balance sheet
| Fiscal year | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 |
|---|---|---|---|
| Cash and equivalents | 3 | 53 | 1 |
| Receivables | 1 | 1 | — |
| Inventory | 0 | 126 | 2 |
| Total current assets | 5 | 438 | 31 |
| Goodwill | 0 | 112 | — |
| Total assets | 24 | 950 | 205 |
| Total current liabilities | 13 | 427 | 236 |
| Short-term debt | — | 469 | 454 |
| Long-term debt | — | 127 | 1 |
| Total debt | 0 | 596 | 1 |
| Total liabilities | 14 | 700 | 288 |
| Shareholders' equity | 259 | 1 | −66 |
| Non-controlling interests and other (assets − liabilities − equity) | −248 | 249 | −17 |
| Net debt (negative = net cash) | −3 | 543 | 1 |
Compare with peers
- Iovance Biotherapeutics, Inc. balance sheet
- Arvinas, Inc. balance sheet
- Adaptive Biotechnologies Corp balance sheet
- Vericel Corp balance sheet
- Vir Biotechnology, Inc. balance sheet
Head to head: IOVA vs MLECARVN vs MLECADPT vs MLEC
More: Biotechnology stocks compared, Health Care sector, rankings of US companies